Tag: Stock

What Happened: Shares of computer processor maker AMD (NASDAQ:AMD) fell 5.1% in the morning session after the Wall Street Journal…

What Happened: Shares of e-commerce marketplace Coupang (NYSE:CPNG) jumped 11.4% in the afternoon session after the company announced it would…

Investing.com — The Dow plunged Friday, as major Wall Street banks kicked off the earnings season with disappointing results, stoking worries about the strength of the upcoming earnings season at a time when inflation jitters remain front and center.

On Friday, Jefferies maintained its hold rating on Tata Consultancy Services (NS:TCS), with a price target (PT) of Rs 4,030. The firm noted that TCS\’s fourth-quarter results surpassed expectations, but cautioned that persistent demand pressures cast a shadow over the growth outlook. Despite a strong deal pipeline, the management\’s conservative commentary, coupled with a continued reduction in headcount and a significant cut in subcontractor use, raised concerns regarding future growth prospects.

Sensex and Nifty plummeted as FPIs sold off, influenced by US inflation and tweak in India-Mauritius tax treaty. Investors are also cautious on valuations, profit booking, and rising commodities prices. EPS growth is likely to moderate in Q4 earnings season which begins today with TCS.

Zerodha Co-Founder Nikhil Kamath has alerted investors about not being part of any WhatsApp group that gives stock recommendations.

HDFC Bank\’s stock reacts to MUFG\’s 20% stake purchase in HDB Financial Services at $9-10 billion valuation pre-IPO.

Sanjiv Bhasin says I \”there is a lot of froth on the markets including the domestic market.\” He discusses market trends, advising caution and specific investments. He further highlights the impact of China on metals, Zomato\’s market performance, as well as InterGlobe\’s dominance despite competitor challenges, recommending strategic investment approaches.

This will be paid on the fourth day from the conclusion of the 29th Annual General Meeting. TCS\’ revenue for the January-March quarter stood at Rs 61,237 crore, up 3.5% on a year-on-year basis and 2.2% YoY in constant currency terms. Full-year revenue was reported at Rs 240,893 crore, up 6.8% YoY and over 3.4% in the CC terms while the net income stood at Rs 46,585 crore jumping by 10.5% YoY.

Ajay Srivastava of Dimensions Corporate says \”we are in that zone where people are comfortable where they are and therefore willing to carry the investment and also make more investment. So, yes, there are fundamental factors, but to me the most important is human psychology. We are feeling good today and when we feel good, we want to do things and become more expensive.\”

Foram Parekh shares insights on CDMO companies\’ positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus\’s earnings improvement, Sun Pharma\’s specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy\’s.

Sudeep Shah, from SBI Securities, predicts market consolidation and bullish movement towards 22,950-23,000. He further Recommends Aditya Birla Capital and MCX stocks and anticipates positive trends in the pharma sector, specifically mentioning Concord Bio.